GUARDANT HEALTH, INC. Debt Securities, Available-for-sale, Amortized Cost
GUARDANT HEALTH, INC. (GH) had Debt Securities, Available-for-sale, Amortized Cost of $1.10 billion as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Credit Losses
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-07-30
- 2026-06-30: Debt Securities, Available-for-sale, Amortized Cost $1.10B.
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost $1.12B.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $1.26B.
- 2024-12-31: Debt Securities, Available-for-sale, Amortized Cost $904.23M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2026-06-30 | $1.10B 10-Q · filed 2026-07-30 |
| 2026-03-31 | $1.12B 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.26B 10-Q · filed 2026-07-30 |
| 2024-12-31 | $904.23M 10-K · filed 2026-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |